Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia

Frontiers in Cardiovascular Medicine

Juhee Song¹  Michelle T. Lee²  Nathaniel R. Wilson³  Astrid Serauto Canache³  Cezar A. Iliescu⁴  Mehmet Cilingiroglu⁵  Teodora Donisan⁵  Clarence D. Gill⁵  Dinu V. Balanescu⁵  Juan Lopez-Mattei⁵  Konstantinos Marmagkiolis⁵  Nicolas Palaskas⁵ 

[1] Division of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, United States;Division of Cardiology, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, United States;Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, United States;Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, United States;Division of Cardiology, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States;Division of Cardiology, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States;

关键词: pericardial effusion;    pericardiocentesis;    thrombocytopenia;    safety;    cancer;   

DOI  :  10.3389/fcvm.2021.638943

来源: Frontiers

【 授权许可】

CC BY